DE2728271C2 - - Google Patents

Info

Publication number
DE2728271C2
DE2728271C2 DE19772728271 DE2728271A DE2728271C2 DE 2728271 C2 DE2728271 C2 DE 2728271C2 DE 19772728271 DE19772728271 DE 19772728271 DE 2728271 A DE2728271 A DE 2728271A DE 2728271 C2 DE2728271 C2 DE 2728271C2
Authority
DE
Germany
Prior art keywords
marking
solution
acid
adjusted
technetium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19772728271
Other languages
German (de)
English (en)
Other versions
DE2728271A1 (de
Inventor
Rudolf Prof. Dipl.-Chem. Dr.Habil. Ddr 8051 Dresden Dd Muenze
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akademie der Wissenschaften der DDR
Original Assignee
Akademie der Wissenschaften der DDR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akademie der Wissenschaften der DDR filed Critical Akademie der Wissenschaften der DDR
Publication of DE2728271A1 publication Critical patent/DE2728271A1/de
Application granted granted Critical
Publication of DE2728271C2 publication Critical patent/DE2728271C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/025—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus inorganic Tc complexes or compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19772728271 1976-07-13 1977-06-23 Verfahren zur markierung organischer stoffe mit technetiumisotopen Granted DE2728271A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DD19381676A DD127200B1 (de) 1976-07-13 1976-07-13 Verfahren zur markierung organischer stoffe mit technetiumisotopen

Publications (2)

Publication Number Publication Date
DE2728271A1 DE2728271A1 (de) 1978-01-19
DE2728271C2 true DE2728271C2 (fi) 1987-09-10

Family

ID=5505105

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772728271 Granted DE2728271A1 (de) 1976-07-13 1977-06-23 Verfahren zur markierung organischer stoffe mit technetiumisotopen

Country Status (2)

Country Link
DD (1) DD127200B1 (fi)
DE (1) DE2728271A1 (fi)

Also Published As

Publication number Publication date
DE2728271A1 (de) 1978-01-19
DD127200A1 (fi) 1977-09-14
DD127200B1 (de) 1986-06-11

Similar Documents

Publication Publication Date Title
DE112018003015B4 (de) 99mTc-MARKIERTES ISONITRIL-ENTHALTENDES GLUCOSEDERIVAT UND HERSTELLUNGSVERFAHREN UND VERWENDUNG DAVON
EP0108253A1 (de) Technetium-99m-Tetraphosphonate zur szintigraphischen Darstellung RES-haltiger Organe und der Lymphgefässe und Verfahren zu deren Herstellung
DE2322758A1 (de) Verfahren zur herstellung von injizierbaren praeparaten des tc99m und/oder in113m und vorrichtung zur durchfuehrung des verfahrens
EP2849807B1 (de) Satz und verfahren zur herstellung eines radiopharmakons
DE2534985C2 (fi)
DE69828779T2 (de) Radionukleiide assoziierte nukleotid-polyphosphate zur bilddarstellung von tumoren
DE69630727T2 (de) Radioaktiven Chitosankomplex und deren Anwendung in Strahlungstherapie
DE2728271C2 (fi)
DE2239791A1 (de) Verfahren zur herstellung von mit indium-113m markiertem humantransferrin
EP2849805B1 (de) Satz und verfahren zur herstellung eines radiopharmakons
EP0003041B1 (de) Technetium-99m-markiertes Diagnostikum zur Darstellung des retikuloendothelialen Systems (RES) und Verfahren zu seiner Herstellung
EP2849808B1 (de) Satz und verfahren zur herstellung eines radiopharmakons
DE102012208377B4 (de) Satz und Verfahren zur Herstellung eines Radiopharmakons
EP1034797B1 (de) Verfahren zur Herstellung eines 18 F-markierten Glykosylierungsreagenz sowie 18 F-Glykosylierungsreagenz und dessen Verwendung
DE2810696C3 (de) Verfahren zur Gewinnung von ω-↑123↑J-Hexadecansäure oder ω↑123↑J-Heptadecansäure und deren Verwendung als Radiopharmaka
DE2625826B2 (de) Hydroxyalkylester der tetrajodterephthalsaeure, verfahren zu deren herstellung und diese enthaltende roentgenkontrastmittel
DE2145282B2 (de) 1 -(Jodhydroxyphenyl)-2-aminopropanderivate, Verfahren zu ihrer Herstellung und diagnostischer Mittel
DE1814671C3 (de) Radioaktive Di-(fluoresceinyl)-quecksilberderivate
EP0335296B1 (de) Tc-99m-w-Alkylphosphinico-1-hydroxyalkan-1,1-diphosphonate enthaltende Präparate zur Knochenszintigraphie sowie Verfahren zur Herstellung dieser Präparate
DE69824147T2 (de) Technetium-99m markierte Diäthylentriaminpentaessigsäure-Diester und Verfahren zu deren Herstellung
DE2218553C3 (de) Substituierte Benzylaminopurinribosid-2'-3'-5'-triester der Nikotinsäure und diese enthaltende Arzneimittel
EP0524639A2 (de) Verfahren zur Markierung von Substanzen mit Technetium oder Rhenium
Buttermann Dicarbonic acid anilides containing radioactive iodine (iodine 131, 123, 125, or 132) as well as their metal and amine salts; methods for the preparation of these compounds and of radioactive functional diagnostics containing them
EP0251046A2 (de) Diagnostikum zur szintigraphischen Darstellung von bösartigen Tumoren
EP0207463A2 (de) Neue Anthracyclin-Tetrasaccharide, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Cytostatika

Legal Events

Date Code Title Description
8141 Disposal/no request for examination
8110 Request for examination paragraph 44
8170 Reinstatement of the former position
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee